| # | Drug | Count |
|---|---|---|
| 0 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 19 |
| 1 | CONJUGATED ESTROGENS | 15 |
| 2 | ESTROGENS, CONJUGATED | 15 |
| 3 | MEDROXYPROGESTERONE ACETATE | 13 |
| 4 | ALENDRONATE SODIUM | 8 |
| 5 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 8 |
| 6 | ESTRADIOL | 6 |
| 7 | ATORVASTATIN CALCIUM | 4 |
| 8 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 |
| 9 | ALPRAZOLAM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 19 | 0.0039 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 2 | MEPROBAMATE | 1 | 0.0008 |
| 3 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 4 | MILK THISTLE | 1 | 0.0005 |
| 5 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 1 | 0.0004 |
| 6 | COLESTIPOL HYDROCHLORIDE | 1 | 0.0004 |
| 7 | ESTROGEN | 1 | 0.0003 |
| 8 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 8 | 0.0003 |
| 9 | CONJUGATED ESTROGENS | 15 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 23 |
| 1 | Endoglycosidase [EPC] | 19 |
| 2 | Estrogen [EPC] | 18 |
| 3 | Benzodiazepine [EPC] | 6 |
| 4 | Aromatase Inhibitor [EPC] | 5 |
| 5 | Corticosteroid [EPC] | 4 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 4 |
| 7 | Microtubule Inhibitor [EPC] | 4 |
| 8 | Alkylating Drug [EPC] | 3 |
| 9 | Loop Diuretic [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 19 | 0.0103 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 23 | 0.0003 |
| 2 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 3 | Estrogen [EPC] | 18 | 0.0001 |
| 4 | Progesterone [EPC] | 2 | 0.0001 |
| 5 | Aromatase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Histamine-2 Receptor Antagonist [EPC] | 4 | 0.0000 |
| 9 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |